Access this stock data via API
Subscribe
Wuxi Biologics (Cayman) Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date 2024 2023 2022 2021
Total reported revenue 20.6B 18.8B 16.7B 10.3B
Cost of revenue 12.2B 11.3B 9.3B 5.5B
Gross profit 8.4B 7.5B 7.3B 4.8B
Operating expense
Research & development 846.0M 867.4M 746.2M 501.6M
Selling general and admin 2.4B 2.0B 1.6B 1.0B
Other operating expenses
Operating income 5.5B 4.9B 5.2B 3.5B
Non operating interest income
Income 386.7M 241.9M 117.4M 58.0M
Expense 173.9M 174.9M 70.4M 39.2M
Other income expense
Pretax income 5.3B 4.6B 5.9B 4.0B
Tax provision 981.3M 665.8M 882.8M 484.5M
Net income 4.4B 3.9B 5.0B 3.5B
Basic EPS 0.8 0.8 1.1 0.8
Diluted EPS 0.8 0.8 1.0 0.8
Basic average shares 4.5B 4.6B 4.6B 3.9B
Diluted average shares 4.5B 4.6B 4.6B 3.9B
EBITDA 7.3B 6.3B 7.6B 4.3B
Net income from continuing op. 5.3B 4.6B 5.9B 4.0B
Minority interests -589.3M -170.9M -129.6M -120.1M
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 6 hours 13 minutes

09:46
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).